Pacific Biosciences of California Inc (PACB)
1.825
+0.06
(+3.69%)
USD |
NASDAQ |
May 03, 16:00
1.85
+0.02
(+1.37%)
After-Hours: 20:00
Pacific Biosciences of California Cash from Financing (Quarterly): -81.60M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -81.60M |
| September 30, 2023 | -0.781M |
| June 30, 2023 | -4.715M |
| March 31, 2023 | 195.99M |
| December 31, 2022 | 0.819M |
| September 30, 2022 | 3.133M |
| June 30, 2022 | 0.455M |
| March 31, 2022 | 5.215M |
| December 31, 2021 | 1.324M |
| September 30, 2021 | 299.66M |
| June 30, 2021 | 2.88M |
| March 31, 2021 | 865.72M |
| December 31, 2020 | 125.88M |
| September 30, 2020 | 107.14M |
| June 30, 2020 | 0.628M |
| March 31, 2020 | 18.20M |
| December 31, 2019 | 18.13M |
| September 30, 2019 | 0.327M |
| June 30, 2019 | 1.40M |
| March 31, 2019 | 6.69M |
| December 31, 2018 | 5.279M |
| September 30, 2018 | 66.52M |
| June 30, 2018 | -0.094M |
| March 31, 2018 | 35.47M |
| December 31, 2017 | 0.096M |
| Date | Value |
|---|---|
| September 30, 2017 | 2.408M |
| June 30, 2017 | 62.90M |
| March 31, 2017 | 3.408M |
| December 31, 2016 | 0.20M |
| September 30, 2016 | 3.027M |
| June 30, 2016 | 32.74M |
| March 31, 2016 | 29.96M |
| December 31, 2015 | 29.56M |
| September 30, 2015 | 2.481M |
| June 30, 2015 | 1.983M |
| March 31, 2015 | 2.434M |
| December 31, 2014 | 17.90M |
| September 30, 2014 | 0.75M |
| June 30, 2014 | 0.38M |
| March 31, 2014 | 22.96M |
| December 31, 2013 | 0.321M |
| September 30, 2013 | 1.448M |
| June 30, 2013 | 11.35M |
| March 31, 2013 | 29.66M |
| December 31, 2012 | 0.002M |
| September 30, 2012 | 0.683M |
| June 30, 2012 | 0.265M |
| March 31, 2012 | 1.755M |
| December 31, 2011 | 0.257M |
| September 30, 2011 | 3.835M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-81.60M
Minimum
Dec 2023
865.72M
Maximum
Mar 2021
82.09M
Average
2.88M
Median
Jun 2021
Cash from Financing (Quarterly) Benchmarks
| AtriCure Inc | -7.862M |
| BioSig Technologies Inc | 2.747M |
| Intellia Therapeutics Inc | 106.48M |
| Shockwave Medical Inc | -0.164M |
| Outset Medical Inc | 33.23M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -57.56M |
| Cash from Investing (Quarterly) | -66.58M |
| Free Cash Flow | -268.02M |
| Free Cash Flow Per Share (Quarterly) | -0.2229 |
| Free Cash Flow to Equity (Quarterly) | -60.32M |
| Free Cash Flow to Firm (Quarterly) | -56.04M |
| Free Cash Flow Yield | -57.91% |